Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescencein situhybridization analysis-Reference-Cited by-同舟云学术

Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescencein situhybridization analysis

Published:2015-11-13 Issue:2 Volume:23 Page:140-145
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Hirobe Megumi¹,Masumori Naoya¹,Tanaka Toshiaki¹,Kitamura Hiroshi¹,Tonooka Akiko²,Hasegawa Tadashi²,Tsukamoto Taiji¹

Affiliation:

1. Department of Urology; Sapporo Medical University; Sapporo Hokkaido Japan

2. Department of Surgical Pathology; Sapporo Medical University; Sapporo Hokkaido Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13007/fullpdf

Reference27 articles.

1. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinoma of children and adolescent;Argani;Am. J. Pathol.,2001

2. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene;Sidhar;Hum. Mol. Genet.,1996

3. A novel CTLC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23);Argani;Oncogene,2003

4. Fusion of splicing factor gene PSF and NonO(p54nrb) to the TFE3 gene in papillary renal cell carcinoma;Clark;Oncogene,1997

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with TFE3 gene fusion;Open Medicine;2024-01-01

2. MiT family translocation renal cell carcinoma with retroperitoneal metastasis in childhood: a case report;Frontiers in Pediatrics;2023-07-17

3. Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report;Frontiers in Pharmacology;2022-08-11

4. A case of metastatic Xp11.2 translocation renal cell carcinoma showing a prolonged response to nivolumab as 6th-line treatment;International Cancer Conference Journal;2022-02-21

5. Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors;Disease Markers;2021-09-01